Clin2
NCT07032558Worth exploringRecruiting

Comparing a new drug to two pain relievers in healthy men

Healthy Volunteer

This trial tests a new drug combination (DW-1021) against two common pain medications (Pelubi CR and Zytram CR) taken separately. Participation helps researchers understand how the drugs compare in healthy men.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
14 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a man between 20 and 40 years old
  • Your body mass index (BMI) is between 18.5 and 24.9 (a measure of weight for height)
  • You weigh at least 50 kg (about 110 lbs)
  • Your blood pressure and heart rate are within normal ranges
  • You are generally healthy with no chronic diseases like diabetes or heart problems
  • You agree to use birth control during and shortly after the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07060209Recruiting· Phase 1
How food affects a new painkiller in healthy adults

This study tests how a meal affects the absorption of a combination painkiller (pelubiprofen and tramadol) in healthy adults. It helps understand if taking the drug with food changes how well it works.

Haiphong, Hai Phong
NCT07144176Recruiting· Phase 1
Comparing two drugs in healthy volunteers

This trial compares two similar drugs (DWJ1511 and DWC202501) to see how they are processed by the body and how safe they are. It is for healthy volunteers to help ensure the drugs work the same way.

Seoul
NCT07841522Not yet recruiting· Phase 1
Safety of a new pain study drug in healthy volunteers

This study tests a new experimental drug (HW243040) in healthy volunteers to see if it is safe and how the body handles it. It includes pain testing to measure how the drug works on pain.

NCT07618247Recruiting· Phase 1
Testing a new drug in healthy adults

This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.

Adelaide, South Australia
NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07618156Not yet recruiting· Phase 1
Testing a new pain drug in healthy volunteers

This study tests a new medicine called KR25102 to see if it is safe and how the body handles it. It may help develop a treatment for pain.

Changsha, Hunan

Hear when a new Healthy Volunteer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.